JJVCI-600X120-Above Article-Toric

In January of this year, the FDA granted the first approval for commercial use of a cloud-based artificial intelligence (AI) program in healthcare. The approval was granted to Arterys, a machine learning platform that was designed for use in cardiology. The program works by analyzing MRI imaging of the heart to accurately measure the volume of each ventricle, allowing physicians to precisely assess heart function. In order to receive this approval, Arterys had to demonstrate to the FDA that the results of its AI algorithm are at least as accurate as those obtained by a human clinician.¹

Arterys can conduct this assessment in 15 seconds on average, whereas a physician would be expected to take 30 minutes to an hour to perform the same task.¹ The program was able to achieve this speed while maintaining human level accuracy after being given a training set of only 1,000 patient cases to learn from. The cloud-based system will automatically receive data from all future patient assessments which will help it to further improve its accuracy.

If you would like to read this complete article, please sign up to become a member!

Fayiz Mahgoub
Associate Editor, Eye Care Technology and Vision Therapy for odsonfb.com. Dr. Fayiz Mahgoub is Chief Creative Officer for Defocus Media and a member of the National Optometric Association's Strategic Planning Committee as well as The Optical Foundation's Advisory Committee. In 2015 he founded the organization Young Leaders in Optometry to bring together the brightest young minds in optometry in order to explore new ways for young optometrists to grow professionally and contribute to the profession. Dr. Mahgoub enjoys sharing his thoughts on a variety of eye care topics as a contributing writer to Optometric Management Magazine, newgradoptometry.com, introwellness.com as well as host of the eye care technology podcast, VisionTECH with Fayiz Mahgoub.

This site uses Akismet to reduce spam. Learn how your comment data is processed.